论文部分内容阅读
目的总结慢性阻塞性肺疾病的康复护理干预效果。方法 100例慢性阻塞性肺疾病患者作为实验研究对象,随机分为参照组和实验组,每组50例。参照组采取常规药物治疗与护理干预,实验组在参照组治疗与护理基础上加行康复护理干预,对比两组护理满意度、治疗前后生活质量、肺功能指标情况。结果实验组患者总满意度(98%)高于参照组(80%),差异具有统计学意义(P<0.05)。两组患者治疗前后一秒用力呼气容积(FEV1)、第一秒用力呼气占用力肺活量比值(FEV1/FCV)对比差异具有统计学意义(P<0.05),且实验组治疗后的FEV1/FCV优于参照组(P<0.05)。实验组治疗前健康调查简表(SF-36)评分为(68.4±4.5)分,治疗后为(103.2±14.0)分;参照组SF-36评分治疗前为(67.8±5.5)分,治疗后为(86.8±13.5)分。治疗前两组SF-36评分比较差异无统计学意义(P>0.05);治疗后两组比较差异具有统计学意义(P<0.05)。结论慢性阻塞性肺疾病患者行康复护理干预效果显著,可以提高护理满意度、改善生活质量,具有临床推广价值。
Objective To summarize the effect of rehabilitation nursing intervention on chronic obstructive pulmonary disease. Methods 100 patients with chronic obstructive pulmonary disease were randomly divided into control group and experimental group, 50 cases in each group. The reference group took routine drug treatment and nursing intervention. The experimental group was given rehabilitation and nursing intervention on the basis of the reference group and the nursing satisfaction, the quality of life before and after treatment and the index of pulmonary function were compared. Results The total satisfaction (98%) in the experimental group was higher than that in the reference group (80%), the difference was statistically significant (P <0.05). The FEV1 and FEV1 / FCV of the two groups before and after treatment were significantly different (P <0.05), and the FEV1 / FCV was better than the reference group (P <0.05). The score of SF-36 in the experimental group was (68.4 ± 4.5) points before treatment and (103.2 ± 14.0) points after the treatment in the experimental group. The score of SF-36 in the reference group was (67.8 ± 5.5) before treatment, (86.8 ± 13.5) points. There was no significant difference in SF-36 score between the two groups before treatment (P> 0.05). After treatment, the difference between the two groups was statistically significant (P <0.05). Conclusion The intervention of rehabilitation nursing in patients with chronic obstructive pulmonary disease has significant effect, which can improve nursing satisfaction and quality of life, and has clinical promotion value.